1,2,3Bello, S. O. T., 4Houkpevi, A., 4Zackari, S., 1,3Tapsoba, A. S. A., *1,3,5Zoure, A. A., 6Ilboudo, P. D., 1,3Ouattara, A. K., 1Traore, L., 3Belemgnegre, M., 1,3,4Zohoncon, T. M., 2,5Diabate, A., and 1,3,4Simpore, J.
1Laboratory of Molecular Biology and Genetics (CERBA/LABIOGENE), UFR/SVT, Joseph KI-ZERBO University, BP 7021 Ouagadougou 03, Burkina Faso
2African Center of Excellence in Biotechnological Innovations for the Elimination of Vector-borne Diseases
(CEA/ITECH-MTV), Nazi BONI University 01BP, 1091 Bobo-Dioulasso 01, Burkina Faso
3Saint Camille Hospital of Ouagadougou (HOSCO), 01 BP 444 Ouagadougou 01, Burkina Faso
4Faculty of Health Sciences, Saint Thomas Aquinas University (USTA), 06 BP 10212, Ouagadougou 06, Burkina Faso
5Institute for Research in Health Sciences (IRSS/CNRST)/Muraz Center, BP 390, Bobo-Dioulasso, Burkina Faso
6University of Fada N’Gourma, Fada N’Gourma, Burkina Faso
*Correspondence to: abdouazaque@gmail.com; Tel: 00 226 50 34 48 01; //orcid.org/0000–0002–9423–024X
Abstract:
Background: Dengue is still a public health problem in tropical countries. This disease, which had almost disappeared in some areas of the world, has become re-emergent in certain parts of the world including Africa. The aim of this study is to determine the seroprevalence and evolution of Dengue virus (DENV) infection from 2020 to 2021 at the Hospital Saint Camille de Ouagadougou (HOSCO), Burkina Faso. Continue reading “Epidemiology of Dengue in patients with febrile syndrome at Saint Camille Hospital, Ouagadougou, Burkina Faso from 2020 to 2021”